News

CRISPR/Cas9 press release
September 23, 2015

Diagenode’s CRISPR/Cas9 polyclonal antibody has been raised against the N-terminus of the Cas9 nuclease, extensively validated and optimized for excellent specificity and high yields in chromatin IP.

Tweets by Diagenode

イベント

すべてのイベントを見る

ニュース

PRESS RELEASE - Diagenode and Alithea Genomics collaborate to offer scalable and affordable RNA-seq services
The Genetics Virtual Week
Diagenode to Provide Cutting Edge Library Preparation Products for MGI in USA, Europe and Asia Pacific

すべてのニュースを見る

The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.

ABOUT SSL CERTIFICATES

>>> Click for Diagenode’s approach to COVID-19

News

CRISPR/Cas9 press releaseSeptember 23, 2015

イベント

ニュース

CRISPR/Cas9 press release
September 23, 2015